Strategic Plan

Pathology Technology Australia (PTA) strategic vision is anchored in five fundamental levers. At the core of everything we do is the drive for patients to have timely and equitable access to critical diagnostic tools.

A Patient Focused Vision

At Pathology Technology Australia, we are passionately committed to advocating for the value our member’s technology  brings to the Australian healthcare landscape. The five strategic levers support our vision and steer our actions and initiatives. Our focused messaging, advocacy, and activities enhance the sector's overall efficacy, sustainability and impact. Our goal is to always ensure the right test for the right patient at the right time.

Our broad member base, Associate Membership, and key health stakeholders drive regular strategic assessment and refresh. This enables effective and adaptive responses to the rapid evolution of our sector.

Join us and add your voice. Your diverse representation brings essential experience to the pathology technology sector and the wider healthcare landscape.

PTA-strategic-levers-diagram-with-key
Direct advocacy

Lever 1 – Direct Advocacy
This is PTA’s main reason for existence. Very few members have local market access and government affairs representatives. PTA takes this role and presses government and statutory bodies in a way that members cannot. Our overarching goal is to reframe pathology in the eyes of government, not as a cost centre, but as a critical enabler of better patient outcomes, healthcare sustainability and economic benefit.

Success in this lever is tangible government action that recognises the economic multiplier of a secure and diverse pathology technology sector with clear sovereign capability entrenched.

We will achieve this through direct advocacy at federal and state levels, multistakeholder congresses and workshops, health economic reports and white papers, and by leveraging patient advocacy.

Member advisory

Lever 2 – Advisory via Members
Our members are our greatest asset and together we hold a combined wealth of valuable information. Tapping this information via our standing committees and Member Advisory Panels (MAPs) and using it to inform consultations with government and statutory bodies maximises outcomes for members and our sector. Expanding our consultative footprint brings us into more discussions at more tables in healthcare and develops a greater level of trust and credibility.

Success appears as requests from government for input, data and opinion. We achieve this through broad input from members via our Government Affairs and Regulatory standing committees and our MAPs – currently in POCT, Genomics and Digital Health and AI.

Strategic Partnerships

Lever 3 – Strategic Partnerships
Collaboration and working with a coalition of organisations that have a shared vision of healthcare in Australia is key to our success. Finding and partnering with the right patient and industry advocacy groups is key to expanding our footprint and having others support our story.

Embedding the value of pathology technology in the voices of collaborators has many positive benefits. It helps promote a consistent message from multiple sources; it helps position PTA as an independent and trusted partner and extends our reach far beyond what we can achieve by ourselves.

Raising awareness

Lever 4 – Raising Awareness
By developing targeted and specific communications, crystalised to ensure we consistently impact the right audience in the right way is the key to the success of this lever.

Building capability through a clear communications plan focussed on the strategic levers and delivered through existing and new channels. These include patient advocacy, such as our “Missing Piece” and Health Economic Report activations. Our PTA Congress forms the flagship event that brings in stakeholders from across the sector to develop a consensus that all can buy into and communicate.

Strengthening

Lever 5 – Strengthening our Member Base
A strong and loyal member base is the core of a successful PTA – from a financial security and broad-based information input perspective. We value the full spectrum of members, from start-ups to highly focussed companies and the largest multi-nationals.

To maintain member loyalty PTA strives to provide the highest value for money in advocacy and activities. These include PTA Academy training programs, our Congress, webinars, newsletters and direct advocacy for individual members. Our committees and MAPs provide members with opportunities to experience and participate in sector-wide interactions, including opportunities to interact with adjacent sectors such as pharmacy and digital health.

PTA is extending the Associate Membership base to include industry adjacent sectors such as pharmaceutical and digital health companies.

The PTA Team – From this comprehensive strategy the PTA team translates a working plan broken into concrete actions, with measurables, owners and timelines. This working plan is reviewed weekly and progress reported to the Board of Directors quarterly.

Scroll to Top